Description: The last three decades have witnessed an important rise in number of people with diabetes in Asia, especially Type 2 Diabetes. Like no other common condition, numerous innovations are currently entering the healthcare system that will soon have a significant impact on management of the condition. This presentation explores the role played by sensors/wearables, artificial intelligence, new drugs and diabetes apps. We assess the realistic potential of such advancements and give an outlook on medium-term pricing and product development.

Description: Critical illness policies pay a large lump sum based upon diagnosis of conditions such as heart attack, stroke, life-threatening cancer, kidney failure, etc. From Record of Society of Actuaries, Volume 26, No. 1, session 119PD of the Las Vegas Spring Meeting.

Description: Panelists discuss the current climate for Critical Illness insurance in the United States. Topics include product design, pricing, underwriting, and marketing high-end products. From Record of Society of Actuaries, Vol. 30, No. 3, Session 11

Description: Panelists address current issues of critical illness products including underwriting, state filing, distribution and marketing. From the Record of the Society of Actuaries, Volume 28, No. 1, Session 33

Description: Panelists discuss the NAIC new loss ratio requirements for limited benefit [supplemental] health plans and companies' responses to these requirements. From the Record of the Society of Actuaries, Vol. 25, No. 2.

Description: This session provides an overview of industry approaches to valuing the liabilities of nontraditional health products such as specific and employer stop loss, provider excess and critical illness. From the Record of the Society of Actuaries, Volume 29, No. 2, Session 117

Description: Critical Illness Insurance is one of the fastest growing insurance products available today. Carriers continue to introduce innovative approaches in second, third, and fourth generation products while refining their pricing, underwriting, and claims adjudication processes. This session will look back at historical trends using Gen Re's longstanding, comprehensive Critical Illness Market Survey, and look forward to potential market changes to occur in the next 18 months.